The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
Viruses
; 15(2), 2023.
Article
in English
| EuropePMC | ID: covidwho-2273984
ABSTRACT
The COVID-19 pandemic has served as a stark reminder that outbreaks of novel pathogens (i.e., those not previously encountered by humans) have always plagued mankind and will continue to do so. The COVID-19 pandemic has also taught us that a single exposure to a novel pathogen is typically not sufficient to build robust population immunity that exists against common respiratory viruses. Robust population-level immunity can be achieved through repeated natural infection (typically at the cost of high mortality and overwhelmed public health resources) and/or repeated vaccination (which may be limited by vaccine availability, a country's economic resources, and/or vaccine hesitancy). Here, we suggest that the broader use of antivirals could be a mitigation strategy to limit severe disease and the burden on healthcare systems during widespread virus circulation while allowing the buildup of population immunity.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Language:
English
Journal:
Viruses
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS